A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  • Kwan, Patrick (Primary Chief Investigator (PCI))
  • Perucca, Piero (Partner Investigator (PI))
  • Nicolo, John-Paul (Partner Investigator (PI))
  • D'Souza, Wendyl Jude (Partner Investigator (PI))
  • Reutens, David (Partner Investigator (PI))

Project: Research

Project Details

StatusActive
Effective start/end date24/06/23 → 25/06/25

Keywords

  • clinical trial
  • Tonic-Clonic Seizures
  • Neurological disorders
  • epilepsy
  • potassium channel opener